CNTG News and Press, Centogene N.V. From 09/01/23

Results from pivotal study published in Diagnostics journal Confirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher disease Could predict clinical course of patients and improve personalized care CAMBRIDGE, Mass. and ROSTOCK, Germany and ...

2023-08-31 16:53:59 ET More on Centogene Centogene GAAP EPS of -Є1.19, revenue of Є47.5M Centogene stock surges ~15% on extending diagnostic pact with Takeda Centogene spikes as H.C. Wainwright initiates Buy with over 200% upside Centogene gets ...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“we” or the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has rec...

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule for August 2023. CENTOGENE representatives...

2023-07-14 06:40:56 ET Centogene N.V. ( NASDAQ: CNTG ) has received notifications from Nasdaq that the company is now in compliance with the minimum bid price requirement and with the minimum market value of publicly held shares requirement. The company was notified by Nasdaq ...

2023-07-12 08:24:50 ET Ault Alliance ( NYSE: AULT ) +152% . Healthcare Triangle ( HCTI ) +127% . Cadrenal Therapeutics ( CVKD ) +61% . Liminal BioSciences  ( LMNL ) +40% to go private in buyout deal with Structured Alpha. BitNil...

Inclusion of 602 patients from 47 countries represents the world’s largest and most heterogeneous Niemann-Pick type C1 disease (NPC1) cohort Study identified 287 unique Pathogenic/Likely Pathogenic (P/LP) variants, 73 of which had never been described before Data reveals novel geno...

Lifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing PR Newswire Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopha...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 30, 2023 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the voting results of the Company...

2023-06-29 10:10:59 ET Gainers: RenovoRx ( RNXT ) +37% . Immunome ( IMNM ) +36% .  DermTech ( DMTK ) +15% . Galera Therapeutics ( GRTX ) +9% . Oncolytics Biotech ( ONCY ) +7% . Losers: BioXcel Therapeutics ( BTA...